Figure 6.
Superdex 200 gel filtration and immunologic characterization of IL-6 in serum from patients with RA (n = 7) and patients with MDS (n = 6). (A) IL-6 concentrations of each fraction assayed using commercial MSD assay and (B) IL-6 concentrations of each fraction assayed using the panoptic IL-6 assay. IL-6, interleukin 6; MDS, myelodysplastic syndrome; MSD, Meso Scale Discovery; SEC, size exclusion column, 
RA 1, 
RA 2, 
RA 3, 
RA 4, 
RA 5, 
RA 6, 
RA 7, 
MDS 1, 
MDS 2, 
MDS 3, 
MDS 4, 
MDS 5, 
MDS 6